Greenhaven Road Capital reported a -9% return in Q3 2025, bringing YTD returns to -9%. Factors included lack of AI investment, no overlap with S&P 500, and insufficient ownership of small, high-growth unprofitable companies benefiting from AI landscape. Check top 5 holdings for 2025 picks. Lifecore Biomedical, Inc. had a 3.63% one-month return and closed at $6.85 per share on November 7, 2025. 15 hedge funds held Lifecore Biomedical, Inc. at the end of Q2 2025. Greenhaven Road Capital emphasized the intrinsic value of Lifecore Biomedical, Inc. in its investor letter. Laughing Water Capital discussed Lifecore Biomedical, Inc. (NASDAQ:LFCR) and its turnaround potential.

Read more at Yahoo Finance: Here’s the Analysis of LifeCore’s (LFCR) Growth Potential